Patience is key!
$ケモセントリックス (CCXI.US)$
ChemoCentryx, Inc.'s (NASDAQ:CCXI) avacopan was the only new molecular entity approved during the month. NMEs are new drug products containing an active ingredient that is marketed for the first time in the U.S. Avacopan, which is to go by the brand name Tavneos, has been approved for treating small blood vessel damage.
It’s all good. let’s go!
ChemoCentryx, Inc.'s (NASDAQ:CCXI) avacopan was the only new molecular entity approved during the month. NMEs are new drug products containing an active ingredient that is marketed for the first time in the U.S. Avacopan, which is to go by the brand name Tavneos, has been approved for treating small blood vessel damage.
It’s all good. let’s go!
免責事項：このコミュニティは、Moomoo Technologies Inc.が教育目的でのみ提供するものです。
さらに詳しい情報
コメント
サインインコメントをする
